July 25, 2017 11:59 AM ET


Company Overview of Iroko Pharmaceuticals Inc.

Executive Profile

Osagie O. Imasogie Esq.

Executive Chairman of the Board and Chief Executive Officer, Iroko Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 5 different industries.

See Board Relationships


Mr. Osagie O. Imasogie, Esq. is the Founder of Iroko Pharmaceuticals, LLC and served as its Chief Executive Officer until July 6, 2016. Mr. Imasogie founded Phoenix IP Ventures in 2004 and served as its Senior Managing Partner. Mr. Imasogie is a Business Executive and Attorney and has extensive professional experience in the fields of law, finance and business management, healthcare and the pharmaceutical industry. He has over 30 years of experience in the Healthcare ...

Corporate Headquarters

One Kew Place
Philadelphia, Pennsylvania 19112

United States

Phone: 267-546-3003
Fax: 267-546-3004

Board Members Memberships

Founder and Chairman of the Board
Executive Chairman of the Board and Chief Executive Officer


Master's Degree
University of Pennsylvania - Law School
Bachelor's Degree
The London School of Economics and Political Science
Master's Degree
The London School of Economics and Political Science

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Iroko Pharmaceuticals Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.